🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kristin R. Knight

Oregon Health & Science University

ORCID: 0000-0002-5701-3537

Also affiliated with Doernbecher Children's Hospital

NeuroscienceBiochemistry, Genetics and Molecular BiologyChemistryMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study”.

Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study

The Lancet Child & Adolescent Health(2021)10.1016/s2352-4642(21)00020-1
N/A
0DataRank · unranked
89 citations

Chunqiao Luo, Joshua Millstein, Kristin R. Knight, Shahrad R. Rassekh, Beth Brooks +8 more

Surveillance of long-term complications after treatment of adult brain tumor survivors—review and evidence-based recommendations

Neuro-Oncology Practice(2022)10.1093/nop/npac053
N/A
0DataRank · unranked
15 citations

Lia M. Halasz, Ny‐Ying Lam, Myron Goldberg, Joe Stuckey, R. Alan Failor +9 more

Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0252
N/A
0DataRank · unranked
25 citations

Kristin R. Knight, Yueh‐Yun Chi, Jemily Malvar, Teresa Rushing, Victoria Mena +9 more

Special considerations in the design and implementation of pediatric otoprotection trials

Journal of Cancer Survivorship(2023)10.1007/s11764-022-01312-x
N/A
0DataRank · unranked
17 citations

Etan Orgel, Kristin R. Knight, Mark Krailo, David R. Freyer

Reevaluation of sodium thiosulfate otoprotection using the consensus International Society of Paediatric Oncology Ototoxicity Scale: A report from the Children's Oncology Group study ACCL0431

Pediatric Blood & Cancer(2023)10.1002/pbc.30550
N/A
0DataRank · unranked
9 citations

Kristin R. Knight, Doojduen Villaluna, Mark Krailo, Adam J. Esbenshade, Lillian Sung +2 more

What's New in Ototoxicity Management?

Perspectives of the ASHA Special Interest Groups(2023)10.1044/2023_persp-23-00153
N/A
0DataRank · unranked
5 citations

Angela C. Garinis, Kristin R. Knight, Dawn Konrad‐Martin, Thais Morata, Gayla L. Poling +4 more

Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment

Ear and Hearing(2024)10.1097/aud.0000000000001592
N/A
0DataRank · unranked
4 citations

Alex E. Hoetink, Dawn Konrad‐Martin, Deborah Berndtson, Khaya D. Clark, Laura Dreisbach +17 more

Remote Field Application of Digital Technology for Hearing Assessments in a Cohort of Pediatric Germ Cell Tumor Survivors

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0203
N/A
0DataRank · unranked
0 citations

Kristin R. Knight, Michelle A. Roesler, Jeannette M. Sample, Jenny N. Poynter, Pablo S. Monterroso

Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin Chemotherapy

Journal of Clinical Oncology(2025)10.1200/jco-24-01861
N/A
0DataRank · unranked
4 citations

Shahrad R. Rassekh, Austin L. Brown, Qi Nie, Adam J. Esbenshade, Kristin R. Knight +11 more